BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20929586)

  • 1. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
    Oliveira NM; Trikha R; McKnight Á
    Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins.
    Saenz DT; Teo W; Olsen JC; Poeschla EM
    J Virol; 2005 Dec; 79(24):15175-88. PubMed ID: 16306589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
    Ulm JW; Perron M; Sodroski J; C Mulligan R
    Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
    Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
    J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
    Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Megabat-Favored, CA-Dependent Susceptibility to Retrovirus Infection.
    Ohkura S; Horie M; Shimizu M; Nakagawa S; Osanai H; Miyagawa Y; Morita R
    J Virol; 2023 Mar; 97(3):e0180322. PubMed ID: 36779757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interfering residues narrow the spectrum of MLV restriction by human TRIM5alpha.
    Maillard PV; Reynard S; Serhan F; Turelli P; Trono D
    PLoS Pathog; 2007 Dec; 3(12):e200. PubMed ID: 18166079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-Associated Early-Stage Antiviral Factor Is a Major Component of Lv2 Restriction.
    Marno KM; O'Sullivan E; Jones CE; Díaz-Delfín J; Pardieu C; Sloan RD; McKnight Á
    J Virol; 2017 May; 91(10):. PubMed ID: 28275184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu.
    Lucas TM; Lyddon TD; Cannon PM; Johnson MC
    J Virol; 2010 Mar; 84(6):2666-74. PubMed ID: 20042505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of murine leukemia viruses that escape from human and rhesus macaque TRIM5αs.
    Ohkura S; Stoye JP
    J Virol; 2013 Jun; 87(11):6455-68. PubMed ID: 23536686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
    Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
    PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression levels of Fv1: effects on retroviral restriction specificities.
    Li W; Yap MW; Voss V; Stoye JP
    Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.
    Yap MW; Nisole S; Stoye JP
    Curr Biol; 2005 Jan; 15(1):73-8. PubMed ID: 15649369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
    Ahi YS; Yimer D; Shi G; Majdoul S; Rahman K; Rein A; Compton AA
    mBio; 2020 Jan; 11(1):. PubMed ID: 31964738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
    Perron MJ; Stremlau M; Lee M; Javanbakht H; Song B; Sodroski J
    J Virol; 2007 Mar; 81(5):2138-48. PubMed ID: 17135314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional evidence for the involvement of microtubules and dynein motor complexes in TRIM5α-mediated restriction of retroviruses.
    Pawlica P; Le Sage V; Poccardi N; Tremblay MJ; Mouland AJ; Berthoux L
    J Virol; 2014 May; 88(10):5661-76. PubMed ID: 24600008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human TRIM5alpha mediated restriction of different HIV-1 subtypes and Lv2 sensitive and insensitive HIV-2 variants.
    Kaumanns P; Hagmann I; Dittmar MT
    Retrovirology; 2006 Nov; 3():79. PubMed ID: 17087820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
    Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lv2, a novel postentry restriction, is mediated by both capsid and envelope.
    Schmitz C; Marchant D; Neil SJ; Aubin K; Reuter S; Dittmar MT; McKnight A
    J Virol; 2004 Feb; 78(4):2006-16. PubMed ID: 14747565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent insights into the mechanism and consequences of TRIM5α retroviral restriction.
    Sastri J; Campbell EM
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):231-8. PubMed ID: 21247355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.